227 related articles for article (PubMed ID: 25045724)
41. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
[TBL] [Abstract][Full Text] [Related]
42. Effect of Different Carriers on in vitro Permeation of Meloxicam through Rat Skin.
Saleem MA; Bala S; Liyakat ; Aeajaz A
Indian J Pharm Sci; 2010 Nov; 72(6):710-8. PubMed ID: 21969742
[TBL] [Abstract][Full Text] [Related]
43. Enhanced local anesthetic action of mepivacaine from the bioadhesive gels.
Cho CW; Choi JS; Shin SC
Pak J Pharm Sci; 2011 Jan; 24(1):87-93. PubMed ID: 21190925
[TBL] [Abstract][Full Text] [Related]
44. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
[TBL] [Abstract][Full Text] [Related]
45. Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations.
Shamsher AA; Charoo NA; Rahman Z; Pillai KK; Kohli K
Pharm Dev Technol; 2014 Feb; 19(1):21-30. PubMed ID: 23281713
[TBL] [Abstract][Full Text] [Related]
46. Assessment of improved buccal permeation and bioavailability of felodipine microemulsion-based cross-linked polycarbophil gel.
Singh M; Kanoujia J; Parashar P; Arya M; Tripathi CB; Sinha VR; Saraf SK; Saraf SA
Drug Deliv Transl Res; 2018 Jun; 8(3):591-601. PubMed ID: 29423833
[TBL] [Abstract][Full Text] [Related]
47. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
48. Enhanced transdermal delivery of pranoprofen from the bioadhesive gels.
Shin SC; Cho CW
Arch Pharm Res; 2006 Oct; 29(10):928-33. PubMed ID: 17121190
[TBL] [Abstract][Full Text] [Related]
49. Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.
Sun F; Sui C; Zhou Y; Liu X; Shi Y; Wu Y; Li Y
Int J Pharm; 2013 Sep; 454(1):532-8. PubMed ID: 23891744
[TBL] [Abstract][Full Text] [Related]
50. Effect of penetration enhancers on in vitro percutaneous penetration of nimesulide through rat skin.
Güngör S; Bergişadi N
Pharmazie; 2004 Jan; 59(1):39-41. PubMed ID: 14964420
[TBL] [Abstract][Full Text] [Related]
51. Formulation and characterization of nystatin gel.
Quiñones D; Ghaly ES
P R Health Sci J; 2008 Mar; 27(1):61-7. PubMed ID: 18450235
[TBL] [Abstract][Full Text] [Related]
52. Biointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: Correlation of swelling and drug delivery performance.
Panda B; Subhadarsini R; Mallick S
Expert Opin Drug Deliv; 2016; 13(5):633-43. PubMed ID: 26878690
[TBL] [Abstract][Full Text] [Related]
53. Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole.
Ahad A; Aqil M; Ali A
Int J Biol Macromol; 2014 Mar; 64():144-9. PubMed ID: 24296403
[TBL] [Abstract][Full Text] [Related]
54. Viscoelastic properties of Carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases.
A-sasutjarit R; Sirivat A; Vayumhasuwan P
Pharm Res; 2005 Dec; 22(12):2134-40. PubMed ID: 16215775
[TBL] [Abstract][Full Text] [Related]
55. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
Bachhav YG; Patravale VB
Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
[TBL] [Abstract][Full Text] [Related]
56. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
[TBL] [Abstract][Full Text] [Related]
57. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
Babu RJ; Pandit JK
Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
[TBL] [Abstract][Full Text] [Related]
58. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
Tawfeek HM; Saleem IY; Roberts M
J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
[TBL] [Abstract][Full Text] [Related]
59. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
[TBL] [Abstract][Full Text] [Related]
60. Hydroxypropyl-β-cyclodextrin grafted polyethyleneimine used as transdermal penetration enhancer of diclofenac sodium.
Yan Y; Xing J; Xu W; Zhao G; Dong K; Zhang L; Wang K
Int J Pharm; 2014 Oct; 474(1-2):182-92. PubMed ID: 25138253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
